Taiko Pharmaceutical (4574.T) traded down -0.38 % during a 24 hours period ending at 03:35 PM Central Europe on Monday 26th. One Taiko Pharmaceutical stock can currently be bought for about JPY 257 on popular exchanges. Current supply of Taiko Pharmaceutical stocks is 50.3 mn. Taiko Pharmaceutical has a current market capitalization of JPY 13.1 bn and approximately JPY 35.6 mn worth of Taiko Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Taiko Pharmaceutical has traded 2.35 % up. Simple moving average of last 200 days is at JPY 276.58. The highest price of past 52 weeks was recorded at JPY 317 on 02/18/2026. 52 weeks low was at JPY 246 on 08/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Muto Seiko (7927.T) traded down -1.05 % and now trades at JPY 2,253. Current market capitalisation for Muto Seiko is JPY 15.7 bn. Current price/earnings ratio for Muto Seiko is 8.34.

  • Nakakita Seisakusho (6496.T) traded down -1.96 % and now trades at JPY 4,600. Current market capitalisation for Nakakita Seisakusho is JPY 15.7 bn. Nakakita Seisakusho has a current price to earnings ratio of 10.09.

  • Hoshi Iryo-sanki (7634.T) traded flat 0 % and now trades at JPY 5,000. Current market capitalisation for Hoshi Iryo-sanki is JPY 15.6 bn. Current price/earnings ratio for Hoshi Iryo-sanki is 11.23.

  • Naigai Tec (3374.T) traded down -3.14 % and now trades at JPY 4,450. Naigai Tec has a market capitalisation of JPY 15.7 bn. Current price/earnings ratio for Naigai Tec is 12.07.

  • Microad (9553.T) traded down -1.38 % and now trades at JPY 562. Microad has a market capitalisation of JPY 15.7 bn. Current price/earnings ratio for Microad is 23.66.

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. is a health care company operating in various countries, including Japan, that specializes in producing and selling non-prescription drugs for various gastrointestinal issues, such as loose stools and bowels, diarrhea, dyspepsia, food and water poisoning, vomiting, and toothache. Additionally, the company produces sanitation control products and bath additives for horticultural use. It also engages in the manufacturing and selling of designated quasi-drugs, such as Trumpet Intestinal Regulator BF for stomach distention, loose stools, and constipation. The company operates globally and is headquartered in Osaka, Japan.